Drive to Zero
Drive to Zero

Zero complications Zero compromises Zero inconsistency

How would your vascular access supplier respond when challenged across these 3 critical needs?

Infection Prevention Icon Infection Prevention
Catheter Selection Icon Catheter Selection
Standards of Care Icon Standards of Care
blue campaign

Teleflex antimicrobial impregnated catheters help you get closer to ZERO.1-4

Proven safe and effective. The protection behind Arrowg+ard Blue Plus® Catheters is Chlorhexidine - a leading worldwide broad-spectrum antiseptic - and silver sulfadiazine.1

Cateter Close Up
Questions worth asking: What’s the best way to reduce the risk of central line-associated bloodstream infections – and who can deliver it?

Effective and reliable...Arrowg+ard Blue Plus® CVCs are proven to reduce CLABSI by 67-100%.1-4

Proven over time with efficacy and safety verified by 30+ clinical studies.5

Lab Technician
Questions worth asking: How does your catheter protect our bottom line?

Protecting patients. Protecting profit.

Arrowg+ard Blue Plus® catheters catheters are proven to reduce CLABSI, thereby reducing the costs associated with treating infections6 – which can exceed $45,0007 per incident due to pharmacy charges, catheter changes, additional days in the ICU, lab tests and extended hospital stays.

Want to Learn More? We Want to Connect With You.

Fill out this simple form to connect with your local Teleflex Vascular Representative for a full review.

I'm interested in learning more about your:

Fill in all fields correctly.A technical error occurred.Thank you for your submission.

References:

  1. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a Second-Generation Venous Catheter Impregnated with Chlorhexidine and Silver Sulfadiazine of Central Catheter-Related Infections. Ann Intern Medicine. 2005; 143: 570-80. Sponsored by Arrow (Teleflex).
  2. Lorente L, Lecuona M, Jimenez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. American Journal of Infection Control. 2014; 42: 321-4.
  3. Lorente L, Lecuona M, Jimenez A, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. American Journal of Infection Control. 2014; 42: 1130-2.
  4. Lorente, L, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. American journal of infection control. 2016; 44(12): 1526-29. Zimlichman, E, et
  5. U.S. Renal Data System. USRDS 2016 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Kidney Diseases. 2016.
  6. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). Atlanta, GA: Centers for Disease Control and Prevention; 2017.
  7. Zimlichman, E, et al. Health Care-Associated Infections - a Meta-analysis of Costs and Financial Impact on the US Health Care System. JAMA Intern Med.2013; 173(22): 2039-46.

Contraindications

The Arrowg+ard Blue Plus® CVC is contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.

Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, ErgoPack, and VPS Rhythm are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.

Last updated 02/07/23

© 2023 Teleflex Incorporated. All rights reserved. MCI-101125-EN-VA-DG

Questions worth asking: Is there a single partner who can best offer the full complement of catheters required to support all of our clinicians' vascular access needs?

More is just not more. More is better.

The Arrow® vascular access portfolio contains a comprehensive selection of catheters designed to accommodate a variety of insertion location and placement techniques to help you drive to ZERO. True Blue is True Choice.

Central Line Catheters: maximize efficiency and satisfaction with solutions to suit all your CVC needs.

Contraindications

The Arrowg+ard Blue Plus® CVC is contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.

Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, ErgoPack, VPS Rhythm and Arrowg+ard Blue Plus are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.

Last updated 02/07/23

© 2023 Teleflex Incorporated. All rights reserved. MCI-101125-EN-VA-DG

Questions worth asking: Why should our patients endure the potential risk of insertion related complications?

Doing our part with innovative products.

Helping CVC inserters more easily hit their mark as standard of practice.

We love to hear from you
Talk to us on your clinical educational needs

  • CVC/PICC/AHDC Ultrasound guided insertion
  • Right line right patient right time – catheter selection
  • Catheter care and maintenance
female surgeon in operating room
medical student smiling

Bringing it all together with Teleflex Academy

teleflex-academy.com
  • Comprehensive and collaborative approach
  • Engaging, enduring, evidence-based curriculum
  • Courses created by accomplished instructors & industry leaders
  • Range of hands-on / classroom, webinars, e-learning & more

Contraindications

The Arrowg+ard Blue Plus® CVC is contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.

Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, ErgoPack, and VPS Rhythm are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.

Last updated 02/07/23

© 2023 Teleflex Incorporated. All rights reserved. MCI-101125-EN-VA-DG